N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone

C156H195Cl3F18N16O12 — CID 159385489

IUPACN-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone
SMILESCc1ccc(CCCNC(=O)COC2CCC(Nc3ccc(C)c(C(F)(F)F)c3)CC2)cc1.Cc1ccc(NC2CCC(OCC(=O)N3CCCN(c4ccc(Cl)cc4)CC3)CC2)cc1C(F)(F)F.Cc1ccc(NC2CCC(OCC(=O)N3CCCN(c4ccccc4)CC3)CC2)cc1C(F)(F)F.Cc1ccc(NC2CCC(OCC(=O)NCCCNc3ccc(Cl)cc3)CC2)cc1C(F)(F)F.Cc1ccc(NC2CCC(OCC(=O)NCCCc3ccc(Cl)cc3)CC2)cc1C(F)(F)F.Cc1ccc(NCCCNC(=O)COC2CCC(Nc3ccc(C)c(C(F)(F)F)c3)CC2)cc1
InChIInChI=1S/C27H33ClF3N3O2.C27H34F3N3O2.C26H34F3N3O2.C26H33F3N2O2.C25H31ClF3N3O2.C25H30ClF3N2O2/c1-19-3-6-22(17-25(19)27(29,30)31)32-21-7-11-24(12-8-21)36-18-26(35)34-14-2-13-33(15-16-34)23-9-4-20(28)5-10-23;1-20-8-9-22(18-25(20)27(28,29)30)31-21-10-12-24(13-11-21)35-19-26(34)33-15-5-14-32(16-17-33)23-6-3-2-4-7-23;1-18-4-7-20(8-5-18)30-14-3-15-31-25(33)17-34-23-12-10-21(11-13-23)32-22-9-6-19(2)24(16-22)26(27,28)29;1-18-5-8-20(9-6-18)4-3-15-30-25(32)17-33-23-13-11-21(12-14-23)31-22-10-7-19(2)24(16-22)26(27,28)29;1-17-3-6-21(15-23(17)25(27,28)29)32-20-9-11-22(12-10-20)34-16-24(33)31-14-2-13-30-19-7-4-18(26)5-8-19;1-17-4-9-21(15-23(17)25(27,28)29)31-20-10-12-22(13-11-20)33-16-24(32)30-14-2-3-18-5-7-19(26)8-6-18/h3-6,9-10,17,21,24,32H,2,7-8,11-16,18H2,1H3;2-4,6-9,18,21,24,31H,5,10-17,19H2,1H3;4-9,16,21,23,30,32H,3,10-15,17H2,1-2H3,(H,31,33);5-10,16,21,23,31H,3-4,11-15,17H2,1-2H3,(H,30,32);3-8,15,20,22,30,32H,2,9-14,16H2,1H3,(H,31,33);4-9,15,20,22,31H,2-3,10-14,16H2,1H3,(H,30,32)
InChIKeyLLLBJFGMEISXQQ-UHFFFAOYSA-N
MW2934.70 g/mol
LogP35.31
Rot. Bonds50

About N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone

N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone (PubChem CID 159385489) has the molecular formula C156H195Cl3F18N16O12 and a molecular weight of 2934.70 g/mol. Its IUPAC name is N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone.

Molecular Properties

Compound NameN-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone
PubChem CID159385489
Molecular FormulaC156H195Cl3F18N16O12
Molecular Weight2934.70 g/mol
Exact Mass2931.39
IUPAC NameN-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone
SMILESCc1ccc(CCCNC(=O)COC2CCC(Nc3ccc(C)c(C(F)(F)F)c3)CC2)cc1.Cc1ccc(NC2CCC(OCC(=O)N3CCCN(c4ccc(Cl)cc4)CC3)CC2)cc1C(F)(F)F.Cc1ccc(NC2CCC(OCC(=O)N3CCCN(c4ccccc4)CC3)CC2)cc1C(F)(F)F.Cc1ccc(NC2CCC(OCC(=O)NCCCNc3ccc(Cl)cc3)CC2)cc1C(F)(F)F.Cc1ccc(NC2CCC(OCC(=O)NCCCc3ccc(Cl)cc3)CC2)cc1C(F)(F)F.Cc1ccc(NCCCNC(=O)COC2CCC(Nc3ccc(C)c(C(F)(F)F)c3)CC2)cc1
InChIInChI=1S/C27H33ClF3N3O2.C27H34F3N3O2.C26H34F3N3O2.C26H33F3N2O2.C25H31ClF3N3O2.C25H30ClF3N2O2/c1-19-3-6-22(17-25(19)27(29,30)31)32-21-7-11-24(12-8-21)36-18-26(35)34-14-2-13-33(15-16-34)23-9-4-20(28)5-10-23;1-20-8-9-22(18-25(20)27(28,29)30)31-21-10-12-24(13-11-21)35-19-26(34)33-15-5-14-32(16-17-33)23-6-3-2-4-7-23;1-18-4-7-20(8-5-18)30-14-3-15-31-25(33)17-34-23-12-10-21(11-13-23)32-22-9-6-19(2)24(16-22)26(27,28)29;1-18-5-8-20(9-6-18)4-3-15-30-25(32)17-33-23-13-11-21(12-14-23)31-22-10-7-19(2)24(16-22)26(27,28)29;1-17-3-6-21(15-23(17)25(27,28)29)32-20-9-11-22(12-10-20)34-16-24(33)31-14-2-13-30-19-7-4-18(26)5-8-19;1-17-4-9-21(15-23(17)25(27,28)29)31-20-10-12-22(13-11-20)33-16-24(32)30-14-2-3-18-5-7-19(26)8-6-18/h3-6,9-10,17,21,24,32H,2,7-8,11-16,18H2,1H3;2-4,6-9,18,21,24,31H,5,10-17,19H2,1H3;4-9,16,21,23,30,32H,3,10-15,17H2,1-2H3,(H,31,33);5-10,16,21,23,31H,3-4,11-15,17H2,1-2H3,(H,30,32);3-8,15,20,22,30,32H,2,9-14,16H2,1H3,(H,31,33);4-9,15,20,22,31H,2-3,10-14,16H2,1H3,(H,30,32)
InChIKeyLLLBJFGMEISXQQ-UHFFFAOYSA-N
XLogP35.31
TPSA315.12 Ų
H-Bond Donors12
H-Bond Acceptors22
Rotatable Bonds50
Heavy Atoms205
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002934.70
LogP ≤ 535.31
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-[4-(4-Chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone
CID 58118411
1-[4-[4-Chloro-3-(trifluoromethyl)phenyl]piperazin-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethanone
CID 123957203
CID 157817902
CID 157817902
1-[4-(4-tert-butylphenyl)piperazin-1-yl]-3-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]propan-1-one;1-[4-(4-tert-butylphenyl)piperidin-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethoxy]cyclohexyl]-4-methyl-3-(trifluoromethyl)aniline;1-[4-(2,4-difluorophenyl)piperidin-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;bis(4-methyl-N-[4-[2-[4-(4-methylphenyl)piperazin-1-yl]ethoxy]cyclohexyl]-3-(trifluoromethyl)aniline);bis(1-[4-(4-methylphenyl)piperazin-1-yl]-3-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]propan-1-one)
CID 158238159
1-[4-(4-tert-butylphenyl)piperazin-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;1-[4-(4-tert-butylphenyl)piperidin-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[4-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethoxy]cyclohexyl]-4-methyl-3-(trifluoromethyl)aniline;1-[4-(4-chlorophenyl)piperazin-1-yl]-3-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]propan-1-one;1-[4-(2,4-difluorophenyl)piperidin-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;bis(4-methyl-N-[4-[2-[4-(4-methylphenyl)piperazin-1-yl]ethoxy]cyclohexyl]-3-(trifluoromethyl)aniline);1-[4-(4-methylphenyl)piperazin-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;1-[4-(4-methylphenyl)piperazin-1-yl]-3-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]propan-1-one
CID 161514436

Frequently Asked Questions

What is the IUPAC name of N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone?
The IUPAC name of N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone (CID 159385489) is N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone.
What is the SMILES notation for N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone?
The canonical SMILES for N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone is Cc1ccc(CCCNC(=O)COC2CCC(Nc3ccc(C)c(C(F)(F)F)c3)CC2)cc1.Cc1ccc(NC2CCC(OCC(=O)N3CCCN(c4ccc(Cl)cc4)CC3)CC2)cc1C(F)(F)F.Cc1ccc(NC2CCC(OCC(=O)N3CCCN(c4ccccc4)CC3)CC2)cc1C(F)(F)F.Cc1ccc(NC2CCC(OCC(=O)NCCCNc3ccc(Cl)cc3)CC2)cc1C(F)(F)F.Cc1ccc(NC2CCC(OCC(=O)NCCCc3ccc(Cl)cc3)CC2)cc1C(F)(F)F.Cc1ccc(NCCCNC(=O)COC2CCC(Nc3ccc(C)c(C(F)(F)F)c3)CC2)cc1.
What is the InChIKey of N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone?
The InChIKey is LLLBJFGMEISXQQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H33ClF3N3O2.C27H34F3N3O2.C26H34F3N3O2.C26H33F3N2O2.C25H31ClF3N3O2.C25H30ClF3N2O2/c1-19-3-6-22(17-25(19)27(29,30)31)32-21-7-11-24(12-8-21)36-18-26(35)34-14-2-13-33(15-16-34)23-9-4-20(28)5-10-23;1-20-8-9-22(18-25(20)27(28,29)30)31-21-10-12-24(13-11-21)35-19-26(34)33-15-5-14-32(16-17-33)23-6-3-2-4-7-23;1-18-4-7-20(8-5-18)30-14-3-15-31-25(33)17-34-23-12-10-21(11-13-23)32-22-9-6-19(2)24(16-22)26(27,28)29;1-18-5-8-20(9-6-18)4-3-15-30-25(32)17-33-23-13-11-21(12-14-23)31-22-10-7-19(2)24(16-22)26(27,28)29;1-17-3-6-21(15-23(17)25(27,28)29)32-20-9-11-22(12-10-20)34-16-24(33)31-14-2-13-30-19-7-4-18(26)5-8-19;1-17-4-9-21(15-23(17)25(27,28)29)31-20-10-12-22(13-11-20)33-16-24(32)30-14-2-3-18-5-7-19(26)8-6-18/h3-6,9-10,17,21,24,32H,2,7-8,11-16,18H2,1H3;2-4,6-9,18,21,24,31H,5,10-17,19H2,1H3;4-9,16,21,23,30,32H,3,10-15,17H2,1-2H3,(H,31,33);5-10,16,21,23,31H,3-4,11-15,17H2,1-2H3,(H,30,32);3-8,15,20,22,30,32H,2,9-14,16H2,1H3,(H,31,33);4-9,15,20,22,31H,2-3,10-14,16H2,1H3,(H,30,32).
What are the key properties of N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone?
N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone has a molecular weight of 2934.70 g/mol, XLogP of 35.31, 50 rotatable bonds, 12 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(4-chloroanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;1-[4-(4-chlorophenyl)-1,4-diazepan-1-yl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyethanone;N-[3-(4-chlorophenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylanilino)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;N-[3-(4-methylphenyl)propyl]-2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxyacetamide;2-[4-[4-methyl-3-(trifluoromethyl)anilino]cyclohexyl]oxy-1-(4-phenyl-1,4-diazepan-1-yl)ethanone is sourced from PubChem (CID 159385489), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).